Academic Health Center
Stay Connected
research-and-clinical-trials

Drug design for Parkinson’s disease starts here

Photo: OakleyOriginals/CC 2.0/ flic.kr/p/5pjoeg

Were drug design a road, it would surely be a Minnesota street fraught with potholes, ice and gravel.

Even the best ideas can fall by the wayside somewhere between the lab and your corner pharmacy in the process of drug discovery and development.

Recently, University of Minnesota Center for Drug Design member, organic chemist and assistant professor Liqiang Chen, Ph.D., published a paper in the Journal of Medicinal Chemistry outlining the discovery of a potent and selective protein-inhibitor. Blocking the protein, Sirtuin 2 (SIRT2), also has the potential to block a primary contributor to Parkinson’s disease from causing harm.

Read more
news-and-notes

New ACA money goes to reaching new patients, expanded student training

Photo: Patrick O'Leary

Recently, the U of M’s Community-University Health Care Center began receiving three new federal grants to fund additional clinic services. Totaling $744,000 over two years, the grants from the U.S. Department of Health and Human Services will allow the Community-University Health Care Center at the University of Minnesota to begin providing combined substance abuse and mental health screenings for approximately 80 percent of patients over age 12 …

Read more
in-the-news

In the News: A new idea for treating Alzheimer’s

Photo: Joey Gannon/CC 2.0/ flic.kr/p/vepwc

Ling Li is taking Alzheimer’s disease research in a new direction.

Recently, Scientific American took a minute to feature her preliminary research into a novel approach to Alzheimer’s drug development.

Read more
news-and-notes

What’s yours is mine … dog germs included

Photo: Tony Alter/CC 2.0/flic.kr/p/a1ytwT

Dog owners and their canine counterparts share more than just love, living space and the occasional bite of food.

Read more
research-and-clinical-trials

Can this drug for Tylenol overdose make inroads with Type 1 diabetes?

Photo: Victor/CC 2.0/ flic.kr/p/hyE2be

A low-cost Tylenol overdose drug already available for cystic fibrosis use will soon enter clinical trials aimed at discovering whether it can aid in treating an additional condition: Type 1 diabetes.

The drug, a natural supplement, is thought to have potential use in the treatment of hypoglycemia, a condition in which too little blood sugar is present in the body.

Read more
news-and-notes

U of M Raptor Center to celebrate 40 years, release rehabilitated birds Sept. 27

The Raptor Center at the University of Minnesota, Carpenter St. Croix Valley Nature Center, and the 3M Foundation will release rehabilitated birds back into the wild at this year’s Fall Raptor Release on Saturday, September 27 from 10 a.m. to 3 p.m. The event will also mark a milestone in The Raptor’s Center 40th anniversary celebrations.

The free and public family event will take place rain or shine at the Carpenter-St. Croix Valley Nature Center, located at 12805 St. Croix Trail S., Hastings, Minn. Please note construction on County Road 21 and St. Croix Trail is ongoing and sections of traffic are single-lane.

Read more